Cargando…

702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington

BACKGROUND: People who inject drugs (PWID) are at high risk for IE and account for a growing proportion of IE cases in the United States. We describe key characteristics of IE and predictors of 90-day mortality among people who do and do not inject drug at two large academic medical centers. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Corcorran, Maria A, Stewart, Jenell C, Lan, Kristine F, Gupta, Ayushi, Muggli, Tanner N, Sharninghausen, Jody C, Takasugi, Jordan, Tietjen, Ty J, Glick, Sara N, Seshadri, Chetan, Koomalsingh, Kevin, Gibbons, Edward F, Harrington, Robert, Dhanireddy, Shireesha, Kim, H Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777948/
http://dx.doi.org/10.1093/ofid/ofaa439.894
_version_ 1783631022830649344
author Corcorran, Maria A
Stewart, Jenell C
Lan, Kristine F
Gupta, Ayushi
Muggli, Tanner N
Sharninghausen, Jody C
Takasugi, Jordan
Tietjen, Ty J
Glick, Sara N
Seshadri, Chetan
Koomalsingh, Kevin
Gibbons, Edward F
Harrington, Robert
Dhanireddy, Shireesha
Dhanireddy, Shireesha
Kim, H Nina
author_facet Corcorran, Maria A
Stewart, Jenell C
Lan, Kristine F
Gupta, Ayushi
Muggli, Tanner N
Sharninghausen, Jody C
Takasugi, Jordan
Tietjen, Ty J
Glick, Sara N
Seshadri, Chetan
Koomalsingh, Kevin
Gibbons, Edward F
Harrington, Robert
Dhanireddy, Shireesha
Dhanireddy, Shireesha
Kim, H Nina
author_sort Corcorran, Maria A
collection PubMed
description BACKGROUND: People who inject drugs (PWID) are at high risk for IE and account for a growing proportion of IE cases in the United States. We describe key characteristics of IE and predictors of 90-day mortality among people who do and do not inject drug at two large academic medical centers. METHODS: We used a string-searching and pattern-matching algorithm within all discharge (DC) summaries to query the electronic medical record (EMR) for cases of IE among adults ≥18 years of age at two academic medical centers in Seattle, Washington from December 1, 2013 to July 31, 2019. All cases were chart reviewed by a member of the study team to confirm a clinical diagnosis of IE and verify housing and PWID status, the latter defined as any injection drug use in the 3 months prior to admission. Microbiology and valve involvement were extracted from DC summaries and chart-reviewed where needed. Deaths were obtained from Washington state death index, which links to our EMR. Descriptive statistics were used to compare PWID and non-PWID with IE, and Kaplan-Meier log rank tests and Cox proportional hazard models were used to assess for predictors of 90-day mortality. RESULTS: We identified 387 patients with IE, 44% (n=166) of whom were PWID. When compared to non-PWID, PWID were younger (median age 33 vs. 55 years, p< 0.001) and more likely to be female (48% vs. 31%, p=0.001), homeless (41% vs. 9%, p< 0.001), have coagulase-positive Staphylococcal IE (69% vs. 32%, p< 0.001), and have right sided IE (66% vs. 26%, p< 0.001). Seventeen percent (n=64) of patients died within 90 days of admission, including 14% (n=23) of PWID and 19% (n=41) of non-PWID, with no difference in 90-day mortality between these groups (log-rank p=0.3). In univariate analyses, having left sided IE was the only predictor of 90-day mortality (HR 4.79, 95% CI 2.18 – 10.5). CONCLUSION: Despite PWID being significantly younger and having a much higher frequency of right sided IE, they had similar 90-day mortality to non-PWID in this contemporary, urban cohort of hospitalized IE patients. Table 1. Demographic Characteristics of People Who Do and Do Not Inject Drugs with Infective Endocarditis at Two Seattle Hospitals, 2014 – 2019 [Image: see text] DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777948
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77779482021-01-07 702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington Corcorran, Maria A Stewart, Jenell C Lan, Kristine F Gupta, Ayushi Muggli, Tanner N Sharninghausen, Jody C Takasugi, Jordan Tietjen, Ty J Glick, Sara N Seshadri, Chetan Koomalsingh, Kevin Gibbons, Edward F Harrington, Robert Dhanireddy, Shireesha Dhanireddy, Shireesha Kim, H Nina Open Forum Infect Dis Poster Abstracts BACKGROUND: People who inject drugs (PWID) are at high risk for IE and account for a growing proportion of IE cases in the United States. We describe key characteristics of IE and predictors of 90-day mortality among people who do and do not inject drug at two large academic medical centers. METHODS: We used a string-searching and pattern-matching algorithm within all discharge (DC) summaries to query the electronic medical record (EMR) for cases of IE among adults ≥18 years of age at two academic medical centers in Seattle, Washington from December 1, 2013 to July 31, 2019. All cases were chart reviewed by a member of the study team to confirm a clinical diagnosis of IE and verify housing and PWID status, the latter defined as any injection drug use in the 3 months prior to admission. Microbiology and valve involvement were extracted from DC summaries and chart-reviewed where needed. Deaths were obtained from Washington state death index, which links to our EMR. Descriptive statistics were used to compare PWID and non-PWID with IE, and Kaplan-Meier log rank tests and Cox proportional hazard models were used to assess for predictors of 90-day mortality. RESULTS: We identified 387 patients with IE, 44% (n=166) of whom were PWID. When compared to non-PWID, PWID were younger (median age 33 vs. 55 years, p< 0.001) and more likely to be female (48% vs. 31%, p=0.001), homeless (41% vs. 9%, p< 0.001), have coagulase-positive Staphylococcal IE (69% vs. 32%, p< 0.001), and have right sided IE (66% vs. 26%, p< 0.001). Seventeen percent (n=64) of patients died within 90 days of admission, including 14% (n=23) of PWID and 19% (n=41) of non-PWID, with no difference in 90-day mortality between these groups (log-rank p=0.3). In univariate analyses, having left sided IE was the only predictor of 90-day mortality (HR 4.79, 95% CI 2.18 – 10.5). CONCLUSION: Despite PWID being significantly younger and having a much higher frequency of right sided IE, they had similar 90-day mortality to non-PWID in this contemporary, urban cohort of hospitalized IE patients. Table 1. Demographic Characteristics of People Who Do and Do Not Inject Drugs with Infective Endocarditis at Two Seattle Hospitals, 2014 – 2019 [Image: see text] DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777948/ http://dx.doi.org/10.1093/ofid/ofaa439.894 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Corcorran, Maria A
Stewart, Jenell C
Lan, Kristine F
Gupta, Ayushi
Muggli, Tanner N
Sharninghausen, Jody C
Takasugi, Jordan
Tietjen, Ty J
Glick, Sara N
Seshadri, Chetan
Koomalsingh, Kevin
Gibbons, Edward F
Harrington, Robert
Dhanireddy, Shireesha
Dhanireddy, Shireesha
Kim, H Nina
702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington
title 702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington
title_full 702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington
title_fullStr 702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington
title_full_unstemmed 702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington
title_short 702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington
title_sort 702. characteristics of infective endocarditis (ie) and predictors of 90-day mortality among people who do and do not inject drugs with ie in seattle, washington
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777948/
http://dx.doi.org/10.1093/ofid/ofaa439.894
work_keys_str_mv AT corcorranmariaa 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT stewartjenellc 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT lankristinef 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT guptaayushi 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT mugglitannern 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT sharninghausenjodyc 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT takasugijordan 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT tietjentyj 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT glicksaran 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT seshadrichetan 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT koomalsinghkevin 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT gibbonsedwardf 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT harringtonrobert 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT dhanireddyshireesha 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT dhanireddyshireesha 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington
AT kimhnina 702characteristicsofinfectiveendocarditisieandpredictorsof90daymortalityamongpeoplewhodoanddonotinjectdrugswithieinseattlewashington